Peritoneal mesothelioma malignant

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
5 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 2 substances
Antimetabolite 1 substance
Supportive / rescue 1 substance
Platinum compound 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Hospices Civils De Lyon Academic
    DOMVANALIMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ZIMBERELIMAB
    2024-517254-99-00 1 country 2025 n=186
    Halted
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Hospices Civils De Lyon Academic 1 Phase II 0
New trials by year
2025
1
← All indication landscapes